CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Genome editing with CRISPR-Cas is often associated with the induction of mutations. However, a team of researchers from the ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

A team of scientists claims that the risk of common conditions like heart disease could be slashed by editing people's ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

ON CRISPR enzyme, will combine with RNA guides for pharma customers. Deal follows HuidaGene agreement, offers 99% cost ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it ...

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...

The White House is honoring three Iowa State researchers for their work in artificial intelligence, genome editing and ...